Xiaoming Liu

7PUBLICATIONS
18CO-AUTHORS
Cancer cell biologyMolecular targetsPharmacogenomicsCancer diagnosisInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 13, 2024
Correction: Liu et al. RANBP2 Activates O-GlcNAcylation through Inducing CEBPα-Dependent OGA Downregulation to Promote Hepatocellular Carcinoma Malignant Phenotypes. Cancers 2021, 13, 3475.

Xiaoming Liu, Xingyu Chen, Mengqing Xiao

|Dec 11, 2023
Pan-Cancer Analysis of the Cuproptosis-Related Gene DLD.

Jiahui Lin, Guowei Wang, Sha Cheng

|Dec 23, 2022
A Comparison of Doxycycline and Amoxicillin Containing Quadruple Eradication Therapy for Treating Helicobacter pylori-Infected Duodenal Ulcers: A Multicenter, Opened, Randomized Controlled Trial in China.

Jingshu Chi, Canxia Xu, Xiaoming Liu

|Mar 25, 2022
Exosomal CagA from Helicobacter pylori aggravates intestinal epithelium barrier dysfunction in chronic colitis by facilitating Claudin-2 expression.

Yinjie Guo, Canxia Xu, Renjie Gong

|Sep 04, 2018
Protective Role of Coxsackie-Adenovirus Receptor in the Pathogenesis of Inflammatory Bowel Diseases.

Xiong Chen, Rui Liu, Xiaoming Liu

|Nov 16, 2017
Group 2 Innate Lymphoid Cells Are Involved in Skewed Type 2 Immunity of Gastric Diseases Induced by Helicobacter pylori Infection.

Rong Li, Xiao-Xia Jiang, Lin-Fang Zhang

Pageof 2

Frequent Collaborators

3 joint publications

Canxia Xu

2 joint publications

Rong Li

2 joint publications

Xiao-Xia Jiang

2 joint publications

Lin-Fang Zhang